Arianna Vanin
Investor Relations Contact chez The Equicom Group, Inc.
Profil
Arianna Vanin is currently the Head of Investor Relations at The Equicom Group, Inc. She previously worked as the Director of Investor Relations at Medicago, Inc.
Postes actifs de Arianna Vanin
| Sociétés | Poste | Début |
|---|---|---|
The Equicom Group, Inc.
 The Equicom Group, Inc. Miscellaneous Commercial ServicesCommercial Services Part of NATIONAL Public Relations (Canada), Inc., The Equicom Group, Inc. provides investor relations and financial communications consulting services. The company is based in Toronto, Canada. The Equicom Group was acquired by NATIONAL Public Relations (Canada), Inc. from TMX Group Ltd. on July 14, 2015. The Canadian company was founded by Craig Armitage, Barry Hildred. | Investor Relations Contact | - |
Anciens postes connus de Arianna Vanin
| Sociétés | Poste | Fin |
|---|---|---|
Medicago, Inc.
 Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Investor Relations Contact | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
The Equicom Group, Inc.
The Equicom Group, Inc. Miscellaneous Commercial ServicesCommercial Services Part of NATIONAL Public Relations (Canada), Inc., The Equicom Group, Inc. provides investor relations and financial communications consulting services. The company is based in Toronto, Canada. The Equicom Group was acquired by NATIONAL Public Relations (Canada), Inc. from TMX Group Ltd. on July 14, 2015. The Canadian company was founded by Craig Armitage, Barry Hildred. | Commercial Services |
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Health Technology |
